▶ 調査レポート

ウェアラブルインジェクターの世界市場分析・規模・シェア・成長・動向・予測:種類別(オンボディ型、オフボディ型)、用途別(腫瘍、糖尿病、自己免疫疾患、心臓血管疾患、感染症)、最終用途産業別(病院、クリニック、在宅医療)

• 英文タイトル:Wearable Injectors Market (Type - On-body Wearable Injectors, Off-body Wearable Injectors; Application - Oncology, Diabetes, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases; End use Industry - Hospitals, Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transparency Market Researchが調査・発行した産業分析レポートです。ウェアラブルインジェクターの世界市場分析・規模・シェア・成長・動向・予測:種類別(オンボディ型、オフボディ型)、用途別(腫瘍、糖尿病、自己免疫疾患、心臓血管疾患、感染症)、最終用途産業別(病院、クリニック、在宅医療) / Wearable Injectors Market (Type - On-body Wearable Injectors, Off-body Wearable Injectors; Application - Oncology, Diabetes, Autoimmune Disorders, Cardiovascular Diseases, Infectious Diseases; End use Industry - Hospitals, Clinics, Home Care Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 / TPM-BG114資料のイメージです。• レポートコード:TPM-BG114
• 出版社/出版日:Transparency Market Research / 2018年6月
• レポート形態:英文、PDF、190ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Global Site License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、ウェアラブルインジェクターの世界市場について調べ、ウェアラブルインジェクターの世界規模、市場動向、市場環境、種類別(オンボディ型、オフボディ型)分析、用途別(腫瘍、糖尿病、自己免疫疾患、心臓血管疾患、感染症)分析、最終用途産業別(病院、クリニック、在宅医療)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・序文・調査範囲・調査手法
・エグゼクティブサマリー
・ウェアラブルインジェクターの世界市場動向
・ウェアラブルインジェクターの世界市場環境
・ウェアラブルインジェクターの世界市場規模
・ウェアラブルインジェクターの世界市場規模:種類別(オンボディ型、オフボディ型)
・ウェアラブルインジェクターの世界市場規模:用途別(腫瘍、糖尿病、自己免疫疾患、心臓血管疾患、感染症)
・ウェアラブルインジェクターの世界市場規模:最終用途産業別(病院、クリニック、在宅医療)
・ウェアラブルインジェクターの世界市場:地域別市場規模・分析
・ウェアラブルインジェクターの北米市場規模・予測
・ウェアラブルインジェクターのアメリカ市場規模・予測
・ウェアラブルインジェクターの中南米市場規模・予測
・ウェアラブルインジェクターのヨーロッパ市場規模・予測
・ウェアラブルインジェクターのアジア市場規模・予測
・ウェアラブルインジェクターの日本市場規模・予測
・ウェアラブルインジェクターの中国市場規模・予測
・ウェアラブルインジェクターのインド市場規模・予測
・ウェアラブルインジェクターの中東市場規模・予測
・ウェアラブルインジェクターのアフリカ市場規模・予測
・競争状況・関連企業情報

Wearable Injectors Market – Overview

This report studies the current as well as future prospects of the global wearable injectors market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of wearable injectors for cancer and diabetes treatment, and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global wearable injectors market with respect to the leading segments based on type, application, end-uses, and region.

Based on type, the global wearable injectors market has been categorized into on-body wearable injectors and off-body wearable injectors. In terms of application, the market has been classified into oncology, diabetes, autoimmune disorders, cardiovascular diseases, infectious diseases, and others. Based on end-user, the global wearable injectors market has been divided into hospitals, clinics, home care settings, and others. Each of the segments has been extensively analyzed based on market related factors such as incidence and prevalence of cancer, diabetes, autoimmune disorders, cardiovascular diseases, and infectious diseases. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the wearable injectors market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global wearable injectors market.

Geographically, the global wearable injectors market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s Five Forces Analysis, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global wearable injectors market.

Key players operating in the global wearable injectors market are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed AG, West Pharmaceutical Services, Inc., CeQur SA., Debiotech S.A., Sensile Medical AG, and SteadyMed Therapeutics, Inc., among others.

The global wearable injectors market has been segmented as follows:

Global Wearable Injectors Market, by Type

On-body Wearable Injectors
Off-body Wearable Injectors
Global Wearable Injectors Market, by Application

Oncology
Diabetes
Autoimmune Disorders
Cardiovascular Diseases
Infectious Diseases
Others
Global Wearable Injectors Market, by End-user

Hospitals
Clinics
Home Care Settings
Others
Global Wearable Injectors Market, by Region

North America
U.S.
Canada
Europe
Germany
France
Italy
Spain
U.K.
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

レポート目次

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Wearable Injectors Market Snapshot

4. Market Overview
4.1. Product Overview
4.2. Market Opportunity Map
4.3. Key Industry Events
4.4. Global Wearable Injectors Market Size (US$ Mn) Forecast, 2016–2026
4.5. Global Wearable Injectors Market Outlook
4.6. Porter’s Five Forces Analysis
4.7. Technology Trends
4.8. Key Merger and Acquisitions

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities

6. Global Wearable Injectors Market Analysis, by Type
6.1. Key Findings
6.2. Introduction
6.3. Global Wearable Injectors Market Value Share Analysis, by Type
6.4. Global Wearable Injectors Market Forecast, by Type
6.4.1. On-body Wearable Injectors
6.4.2. Off-body Wearable Injectors
6.5. Global Wearable Injectors Market Analysis, by Type
6.6. Global Wearable Injectors Market Attractiveness Analysis, by Type

7. Global Wearable Injectors Market Analysis, by Application
7.1. Key Findings
7.2. Introduction
7.3. Global Wearable Injectors Market Value Share Analysis, by Application, 2017 and 2026
7.4. Global Wearable Injectors Market Forecast, by Application
7.4.1. Oncology
7.4.2. Diabetes
7.4.3. Autoimmune Disorders
7.4.4. Cardiovascular Diseases
7.4.5. Infectious Diseases
7.4.6. Others
7.5. Global Wearable Injectors Market Analysis, by Application, 2016–2026
7.6. Global Wearable Injectors Market Attractiveness Analysis, by Application, 2016–2026

8. Global Wearable Injectors Market Analysis, by End-user
8.1. Introduction
8.2. Key Findings
8.3. Global Wearable Injectors Market Value Share Analysis, by End-user
8.4. Global Wearable Injectors Market Forecast, by End-user
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Home Care Settings
8.4.4. Others
8.5. Global Wearable Injectors Market Analysis, by End-user
8.6. Global Wearable Injectors Market Attractiveness Analysis, by End-user

9. Global Wearable Injectors Market Analysis, by Region
9.1. Global Wearable Injectors Market Scenario, by Region
9.2. Global Wearable Injectors Market Value Share Analysis, by Region
9.3. Global Wearable Injectors Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Wearable Injectors Market Attractiveness Analysis, by Region

10. North America Wearable Injectors Market Analysis
10.1. Key Findings
10.2. North America Wearable Injectors Market Overview
10.3. North America Wearable Injectors Market Value Share Analysis, by Country
10.4. North America Wearable Injectors Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Wearable Injectors Market Value Share Analysis, by Type
10.6. North America Wearable Injectors Market Forecast, by Type
10.6.1. On-body Wearable Injectors
10.6.2. Off-body Wearable Injectors
10.7. North America Wearable Injectors Market Value Share Analysis, by Application
10.8. North America Wearable Injectors Market Forecast, by Application
10.8.1. Oncology
10.8.2. Diabetes
10.8.3. Autoimmune Disorders
10.8.4. Cardiovascular Diseases
10.8.5. Infectious Diseases
10.8.6. Others
10.9. North America Wearable Injectors Market Value Share Analysis, by End-user
10.10. North America Wearable Injectors Market Forecast, by End-user
10.10.1. Hospitals
10.10.2. Clinics
10.10.3. Home Care Settings
10.10.4. Others
10.11. North America Wearable Injectors Market Attractiveness Analysis

11. Europe Wearable Injectors Market Analysis
11.1. Key Findings
11.2. Europe Wearable Injectors Market Overview
11.3. Europe Wearable Injectors Market Value Share Analysis, by Country/Sub-region
11.4. Europe Wearable Injectors Market Forecast, by Country/Sub-region
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Wearable Injectors Market Value Share Analysis, by Type
11.6. Europe Wearable Injectors Market Forecast, by Type
11.6.1. On-body Wearable Injectors
11.6.2. Off-body Wearable Injectors
11.7. Europe Wearable Injectors Market Value Share Analysis, by Application
11.8. Europe Wearable Injectors Market Forecast, by Application
11.8.1. Oncology
11.8.2. Diabetes
11.8.3. Autoimmune Disorders
11.8.4. Cardiovascular Diseases
11.8.5. Infectious Diseases
11.8.6. Others
11.9. Europe Wearable Injectors Market Value Share Analysis, by End-user
11.10. Europe Wearable Injectors Market Forecast, by End-user
11.10.1. Hospitals
11.10.2. Clinics
11.10.3. Home Care Settings
11.10.4. Others
11.11. Europe Wearable Injectors Market Attractiveness Analysis

12. Asia Pacific Wearable Injectors Market Analysis
12.1. Key Findings
12.2. Asia Pacific Wearable Injectors Market Overview
12.3. Asia Pacific Wearable Injectors Market Value Share Analysis, by Country/Sub-region
12.4. Asia Pacific Wearable Injectors Market Forecast, by Country/Sub-region
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Wearable Injectors Market Value Share Analysis, by Type
12.6. Asia Pacific Wearable Injectors Market Forecast, by Type
12.6.1. On-body Wearable Injectors
12.6.2. Off-body Wearable Injectors
12.7. Asia Pacific Wearable Injectors Market Value Share Analysis, by Application
12.8. Asia Pacific Wearable Injectors Market Forecast, by Application
12.8.1. Oncology
12.8.2. Diabetes
12.8.3. Autoimmune Disorders
12.8.4. Cardiovascular Diseases
12.8.5. Infectious Diseases
12.8.6. Others
12.9. Asia Pacific Wearable Injectors Market Value Share Analysis, by End-user
12.10. Asia Pacific Wearable Injectors Market Forecast, by End-user
12.10.1. Hospitals
12.10.2. Clinics
12.10.3. Home Care Settings
12.10.4. Others
12.11. Asia Pacific Wearable Injectors Market Attractiveness Analysis

13. Latin America Wearable Injectors Market Analysis
13.1. Key Findings
13.2. Latin America Wearable Injectors Market Overview
13.3. Latin America Wearable Injectors Market Value Share Analysis, by Country/Sub-region
13.4. Latin America Wearable Injectors Market Forecast, by Country/Sub-region
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America
13.5. Latin America Wearable Injectors Market Value Share Analysis, by Type
13.6. Latin America Wearable Injectors Market Forecast, by Type
13.6.1. On-body Wearable Injectors
13.6.2. Off-body Wearable Injectors
13.7. Latin America Wearable Injectors Market Value Share Analysis, by Application
13.8. Latin America Wearable Injectors Market Forecast, by Application
13.8.1. Oncology
13.8.2. Diabetes
13.8.3. Autoimmune Disorders
13.8.4. Cardiovascular Diseases
13.8.5. Infectious Diseases
13.8.6. Others
13.9. Latin America Wearable Injectors Market Value Share Analysis, by End-user
13.10. Latin America Wearable Injectors Market Forecast, by End-user
13.10.1. Hospitals
13.10.2. Clinics
13.10.3. Home Care Settings
13.10.4. Others
13.11. Latin America Wearable Injectors Market Attractiveness Analysis

14. Middle East and Africa Wearable Injectors Market Analysis
14.1. Key Findings
14.2. Middle East and Africa Wearable Injectors Market Overview
14.3. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Country/Sub-region
14.4. Middle East and Africa Wearable Injectors Market Forecast, by Country/Sub-region
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Type
14.6. Middle East and Africa Wearable Injectors Market Forecast, by Type
14.6.1. On-body Wearable Injectors
14.6.2. Off-body Wearable Injectors
14.7. Middle East and Africa Wearable Injectors Market Value Share Analysis, by Application
14.8. Middle East and Africa Wearable Injectors Market Forecast, by Application
14.8.1. Oncology
14.8.2. Diabetes
14.8.3. Autoimmune Disorders
14.8.4. Cardiovascular Diseases
14.8.5. Infectious Diseases
14.8.6. Others
14.9. Middle East and Africa Wearable Injectors Market Value Share Analysis, by End-user
14.10. Middle East and Africa Wearable Injectors Market Forecast, by End-user
14.10.1. Hospitals
14.10.2. Clinics
14.10.3. Home Care Settings
14.10.4. Others
14.11. Middle East and Africa Wearable Injectors Market Attractiveness Analysis

15. Competition Landscape
15.1. Wearable Injectors Market Share Analysis By Company, 2017
15.2. Company Profiles
15.2.1. Becton, Dickinson and Company
15.2.1.1. Company Profiles
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. F. Hoffmann-La Roche Ltd.
15.2.2.1. Company Profiles
15.2.2.2. Business Overview
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Tandem Diabetes Care, Inc.
15.2.3.1. Company Profiles
15.2.3.2. Business Overview
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. Insulet Corporation
15.2.4.1. Company Profiles
15.2.4.2. Business Overview
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5. Ypsomed AG
15.2.5.1. Company Profiles
15.2.5.2. Business Overview
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. West Pharmaceutical Services, Inc.
15.2.6.1. Company Profiles
15.2.6.2. Business Overview
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. CeQur SA.
15.2.7.1. Company Profiles
15.2.7.2. Business Overview
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Debiotech S.A.
15.2.8.1. Company Profiles
15.2.8.2. Business Overview
15.2.8.3. Strategic Overview
15.2.8.4. SWOT Analysis
15.2.9. Sensile Medical AG
15.2.9.1. Company Profiles
15.2.9.2. Business Overview
15.2.9.3. Strategic Overview
15.2.9.4. SWOT Analysis
15.2.10. SteadyMed Therapeutics, Inc.
15.2.10.1. Company Profiles
15.2.10.2. Business Overview
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis

List of Tables

Table 01: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 02: Global Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global Wearable Injectors Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 07: North America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 11: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 12: Europe Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 15: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 16: Asia Pacific Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 17: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 19: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 20: Latin America Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Type, 2016–2026
Table 23: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 24: Middle East & Africa Wearable Injectors Market Size (US$ Mn) Forecast, by End-user, 2016–2026